|
Julio Rosenstock, M.D., is the director of the Dallas Diabetes and Endocrine Center at Medical City, an endocrine practice and clinical research facility. He is also a clinical professor of medicine at the University of Texas Southwestern Medical Center at Dallas. He is board-certified in internal medicine, endocrinology and metabolism, member of numerous professional societies and serves as the representative of The Endocrine Society to NDEP (National Diabetes Education Program sponsored by NIH and CDC).
His clinical and research activities have focused on intensive diabetes management strategies exploring novel therapies to improve glycemic control to prevent and retard diabetic complications. Dr Rosenstock’s main interest has been early insulin intervention with combination strategies to reach glycemic targets in type 2 diabetes. He serves on the editorial board of Practical Diabetology and Cardiovascular Diabetology and is an active reviewer for several journals.
| 